- Home
- ACB vs TKNO Comparison
ACB vs TKNO Comparison
Compare ACB & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACB | TKNO |
|---|---|---|
| Founded | 2013 | 1996 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 241.0M | 214.1M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | ACB | TKNO |
|---|---|---|
| Price | $4.23 | $3.91 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.5M | 199.6K |
| Earning Date | 02-04-2026 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $263,570,704.00 | $39,801,000.00 |
| Revenue This Year | $11.82 | $8.79 |
| Revenue Next Year | $8.58 | $10.52 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 23.89 | 9.50 |
| 52 Week Low | $3.42 | $3.60 |
| 52 Week High | $6.91 | $10.37 |
Technical Indicators
Market Signals| Indicator | ACB | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 40.86 | 38.84 |
| Support Level | $4.15 | $3.85 |
| Resistance Level | $4.39 | $4.26 |
| Average True Range (ATR) | 0.16 | 0.27 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 23.15 | 48.87 |
Price Performance
Historical ComparisonAbout ACB Aurora Cannabis Inc.
Aurora Cannabis Inc headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company operates in Canada, it has expanded internationally through medical cannabis exporting agreements. The company opertes in Canada, Europe, Australia, and Others, with majority revenue from Canada.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.